The clinical outcome of intracranial hemangioblastomas treated with linac-based stereotactic radiosurgery and radiotherapy

Recent publications have reported stereotactic radiosurgery as an effective and safe treatment for intracranial hemangioblastomas. however,because of the low incidence of these particular tumors,reports on large patient number studies have not yet been available. the objective of this study was to analyze the clinical results of 14 patients with 56 intracranial hemangioblastomas treated with linear accelerator (linac)-based stereotactic radiosurgery (srs) and radiotherapy (srt) in the same institute. the median age of patients was 41 years (range,28-73 years). nine of the patients (64%) had von hippel-lindau disease. a total of 39 lesions (70%) were treated with cyberknife (ck),and 17 lesions (30%) were treated with x-knife. the median pretreatment volume was 0.26 cm3 (range,0.026-20.4 cm3). the median marginal dose was 20 gy (range,10-32 gy) in 1 fraction (range,1-10 fractions). the median follow-up time was 24 months (range,11-89 months). at the last follow-up,47 tumors (84%) were stable,7 (13%) decreased and 2 (4%) increased. the 1-,2-and 6-year local control rates were 98%,88% and 73%,respectively. no radiation complications were observed in this study. there was a trend toward local failure only in cystic tumors,but this trend was not found to be statistically significant. srs/srt achieved a high local control rate in intracranial hemangioblastomas without radiation-induced complications. © 2014 the author.